Lower-middle income (World Bank) vs Singapore: Hypertension: effective treatment coverage (controlled hypertension)
Lower-middle income (World Bank)
13.9%
in 2019
Singapore
38.8%
in 2019
Lower-middle income (World Bank) rank
12th
Singapore rank
11th
Hypertension: effective treatment coverage (controlled hypertension) over time
- Lower-middle income (World Bank)
- Singapore
How they compare
Singapore currently reports 38.8% against 13.9% in Lower-middle income (World Bank), a difference of 24.9%.
That makes Singapore's figure about 2.8 times Lower-middle income (World Bank)'s.
Across all 30 years both countries report, Singapore has been ahead every year.
Lower-middle income (World Bank) ranks 12th and Singapore ranks 11th of 17 groups.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lower-middle income (World Bank) | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 3.1% | 6.8% | 3.7% | Singapore |
| 2000s | 6.2% | 16.4% | 10.2% | Singapore |
| 2010s | 11.2% | 32.1% | 20.9% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), Lower-middle income (World Bank) or Singapore?
- Singapore, at 38.8% against 13.9% in Lower-middle income (World Bank) as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between Lower-middle income (World Bank) and Singapore?
- 24.9%, with Singapore ahead.
- How many years of comparable data are there for Lower-middle income (World Bank) and Singapore?
- 30 years are reported by both, from 1990 to 2019.
- How do Lower-middle income (World Bank) and Singapore rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- Lower-middle income (World Bank) ranks 12th and Singapore ranks 11th of 17 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.